Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.

@article{Palazzuoli2006ErythropoietinIA,
  title={Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.},
  author={Alberto Palazzuoli and Donald S. Silverberg and Francesca Iovine and Stefano Capobianco and Giovanna Giannotti and Anna Maria Calabr{\`o} and Stella Maria Campagna and Ranuccio Nuti},
  journal={American heart journal},
  year={2006},
  volume={152 6},
  pages={1096.e9-15}
}
BACKGROUND Anemia is now recognized as being a common finding in CHF and is associated with increased mortality and morbidity. However, it is uncertain whether the anemia is actually causing the worse prognosis or is merely a marker of more severe cardiac disease. Previous intervention studies with subcutaneous (s.c.) beta-EPO in combination with iron have either been uncontrolled or case-controlled studies. We report a randomized, double-blind, placebo-controlled study of the combination of s… CONTINUE READING
79 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 79 extracted citations

Similar Papers

Loading similar papers…